ストックスクリーナーアプリを入手
14.15
1.46%
-0.21
アフターアワーズ：
14.15
前日終値:
$14.36
開ける：
$14.08
24時間の取引高:
124.28K
Relative Volume:
0.73
時価総額：
$516.44M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-11.84%
1か月 パフォーマンス:
+25.11%
6か月 パフォーマンス:
-13.77%
1年 パフォーマンス:
-30.98%
1日の値動き範囲:
$13.88
$15.06
1週間の範囲:
$13.88
$17.45
52週間の値動き範囲:
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
RAPP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
14.15 | 524.11M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-07-02 | 開始されました | Jefferies | Buy |
| 2024-07-02 | 開始されました | Stifel | Buy |
| 2024-07-02 | 開始されました | TD Cowen | Buy |
Rapport Therapeutics Inc (RAPP) 最新ニュース
How does Rapport Therapeutics Inc. generate profit in a changing economyBreakout Stocks Updates With Proven Results - jammulinksnews.com
What institutional investors are buying Rapport Therapeutics Inc. stockTop Growth Strategy From AI Tools - jammulinksnews.com
Will Rapport Therapeutics Inc. rebound enough to break evenReal Market Tracker with Price Action Tools - Newser
What is the dividend policy of Rapport Therapeutics Inc. stockExpert Picks Alerts For Beginners - jammulinksnews.com
Market reaction to Rapport Therapeutics Inc.’s recent newsFree Capital Efficiency Optimized Stock Alerts - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsDaily Market Momentum Summary and Strategy - Newser
Is Ovid Therapeutics Inc. stock poised for growthStock Market Watch with Smart Filters - Newser
How to read the order book for Rapport Therapeutics Inc.Portfolio Risk Distribution Analysis Tool - Newser
Applying chart zones and confluence areas to Rapport Therapeutics Inc.Technical Long-Term Outlook and Recap Guide - Newser
How Rapport Therapeutics Inc. stock performs during market volatilityTechnical Setup Guide for Daily Watchlist - Newser
Rapport Therapeutics Inc. Recovery Hinges on Volume BreakoutAI Screening for Swing Trade Picks Finds Momentum - metal.it
Is Rapport Therapeutics Inc. stock overvalued or undervaluedPost Market Opportunities For Consistent Profits - jammulinksnews.com
Bollinger Bands Show Potential Breakout in Rapport Therapeutics Inc.Short Window Trade Insight Forecast - beatles.ru
Can Rapport Therapeutics Inc. Regain Momentum After BreakdownAI Forecast for Trending Stocks Indicates Upside - metal.it
Volume Surge May Signal Institutional Interest in Rapport Therapeutics Inc.Pattern Detection for Entry Confirmation Enabled - metal.it
Why Ferrovial SE stock attracts strong analyst attentionSafe Entry Screening with Data Backed Analysis - Newser
Rapport Therapeutics Inc. Could See a Relief Rally From SupportWatchlist for Smart Swing Trading Updated - metal.it
How Efficient Is Rapport Therapeutics Inc. at Controlling Operating CostsTrend Following Trades - metal.it
Should I hold or sell Rapport Therapeutics Inc. stock in 2025High-velocity capital appreciation - jammulinksnews.com
What are the technical indicators suggesting about Rapport Therapeutics Inc.Superior profit margins - jammulinksnews.com
Is it the right time to buy Rapport Therapeutics Inc. stockSkyrocketing profit margins - jammulinksnews.com
What is the risk reward ratio of investing in Rapport Therapeutics Inc. stockCapitalize on market momentum for profits - jammulinksnews.com
How strong is Rapport Therapeutics Inc. company’s balance sheetCapitalize on market trends early - jammulinksnews.com
What makes Rapport Therapeutics Inc. stock price move sharplyFree Wealth Planning Blueprint - jammulinksnews.com
What are Rapport Therapeutics Inc. company’s key revenue driversMarket-beating returns - jammulinksnews.com
What is Rapport Therapeutics Inc. company’s growth strategyStay ahead with daily expert stock picks - jammulinksnews.com
Is Rapport Therapeutics Inc. a growth stock or a value stockMarket-crushing profits - jammulinksnews.com
Is Rapport Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideLow Volatility High Yield Stocks - Newser
Why Rapport Therapeutics Inc. stock attracts strong analyst attention5x Profit Potential - Newser
How TRGP stock performs during market volatilityInvestor Favorite Picks - Newser
What analysts say about Rapport Therapeutics Inc. stockDynamic profit opportunities - Autocar Professional
When is the best time to buy Rapport Therapeutics Inc. stockOutstanding yields - jammulinksnews.com
What drives Rapport Therapeutics Inc. stock priceOutstanding stock performance - PrintWeekIndia
How Rapport Therapeutics Inc. stock reacts to Fed policy changesMarket-leading capital gains - jammulinksnews.com
Is Rapport Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com
Rapport Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - Autocar Professional
How the (RAPP) price action is used to our Advantage - news.stocktradersdaily.com
Rapport Therapeutics Inc (RAPP) 財務データ
Rapport Therapeutics Inc (RAPP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Rapport Therapeutics Inc (RAPP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Bredt David | Chief Scientific Officer |
Jun 16 '25 |
Sale |
11.00 |
8,500 |
93,522 |
443,642 |
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):